Delivery Order SPE2DB20D1110-SPE2DB24FK35T
Award Date
7/8/24
Potential Completion Date
7/9/24
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp is for the delivery of 4,566,347,690 units of the Boostrix TDAP vaccine syringe (0.5mL). The $22,644.24 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) with a completion date of November 7, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The $7,319.00 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on July 8, 2024 with a completion date of July 9, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, is for the delivery of Boostrix TDAP vaccine syringes in 0.5 ml doses. The contract has a ceiling value of $1,546.68 and an ultimate completion date of May 16, 2024. This order was placed by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense (DoD), under an Indefinite Delivery Contract (IDC) with Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,361.14 firm-fixed-price delivery order is for the supply of 4,565,191,455 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a period of performance ending on July 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,062.24 and an ultimate completion date of July 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, the...
This federal contract award to AmerisourceBergen Drug Corporation's Corporate Office division is for the delivery of 4,565,463,591 units of the Boostrix TDAP vaccine syringe (0.5 mL) to the Defense Logistics Agency (DLA) Troop Support Medical. The $5,061.60 firm-fixed-price delivery order was issued under an existing Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA for providing a comprehensive range of medical commodities to support...
The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of 4,564,353 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). The contract has a ceiling value of $36,781.92 and an ultimate completion date of April 23, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,097.72 firm fixed-price delivery order is for the supply of 4,565,469,335 units of the BOOSTRIX TDAP vaccine syringe (0.5ML). This award is not associated with any set-aside designation. The contract has an ultimate completion date of August 16, 2024. Amerisourcebergen has a significant Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract, valued at $6,444.50, was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,427.58, is for the delivery of 4,567,957,139 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This is a firm fixed-price delivery order contract with an ultimate completion date of April 18, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp...